HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Amos Selected Research

methotrexate- gamma- 1,2- dimyristoylphosphatidylethanolamine

4/2000The suppression of rat collagen-induced arthritis and inhibition of macrophage derived mediator release by liposomal methotrexate formulations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Amos Research Topics

Disease

2Experimental Arthritis
10/2012 - 04/2000
2Arthritis (Polyarthritis)
10/2012 - 04/2000
2Rheumatoid Arthritis
10/2006 - 12/2001
1Pathologic Processes
10/2012
1Osteoarthritis
10/2006
1Infections
10/2006
1Necrosis
10/2006
1Dry Eye Syndromes (Dry Eye Syndrome)
09/2002
1Human Influenza (Influenza)
11/2001

Drug/Important Bio-Agent (IBA)

1Proteins (Proteins, Gene)FDA Link
10/2012
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2012
1Green Fluorescent ProteinsIBA
10/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2006
1beta-Galactosidase (Lactaid)IBA
10/2006
1NF-KappaB Inhibitor alphaIBA
10/2006
1Fluorescein (Funduscein)FDA LinkGeneric
09/2002
1Interleukin-2 Receptors (IL 2 Receptor)IBA
12/2001
1HLA-A*02:01 antigenIBA
11/2001
1AntigensIBA
11/2001
1Methotrexate (Mexate)FDA LinkGeneric
04/2000
1erucylphosphocholineIBA
04/2000
1Liposomes (Liposome)IBA
04/2000
1methotrexate- gamma- 1,2- dimyristoylphosphatidylethanolamineIBA
04/2000

Therapy/Procedure

2Therapeutics
10/2012 - 04/2000